A lack of peptide binding and decreased thermostability suggests that the CASKIN2 scaffolding protein SH3 domain may be vestigial
Tóm tắt
CASKIN2 is a neuronal signaling scaffolding protein comprised of multiple ankyrin repeats, two SAM domains, and one SH3 domain. The CASKIN2 SH3 domain for an NMR structural determination because its peptide-binding cleft appeared to deviate from the repertoire of aromatic enriched amino acids that typically bind polyproline-rich sequences. The structure demonstrated that two non-canonical basic amino acids (K290/R319) in the binding cleft were accommodated well in the SH3 fold. An K290Y/R319W double mutant restoring the typical aromatic amino acids found in the binding cleft resulted in a 20 °C relative increase in the thermal stability. Considering the reduced stability, we speculated that the CASKIN2 SH3 could be a nonfunctional remnant in this scaffolding protein. While the NMR structure demonstrates that the CASKIN2 SH3 domain is folded, its cleft has suffered two substitutions that prevent it from binding typical polyproline ligands. This observation led us to additionally survey and describe other SH3 domains in the Protein Data Bank that may have similarly lost their ability to promote protein-protein interactions.
Tài liệu tham khảo
Weng Y-L, Liu N, DiAntonio A, Broihier HT. The cytoplasmic adaptor protein Caskin mediates Lar signal transduction during Drosophila motor axon guidance. J Neurosci. 2011;31:4421–33.
Good MC, Zalatan JG, Lim WA. Scaffold proteins: hubs for controlling the flow of cellular information. Science. 2011;332:680–6.
Bornberg-Bauer E. Signals: tinkering with domains. Sci Signal. 2010;3:pe31–1.
Tabuchi K, Biederer T, Butz S, Sudhof TC. CASK participates in alternative tripartite complexes in which Mint 1 competes for binding with caskin 1, a novel CASK-binding protein. J Neurosci. 2002;22:4264–73.
Butz S, Okamoto M, Sudhof TC. A tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Cell. 1998;94:773–82.
Stafford RL, Ear J, Knight MJ, Bowie JU. The molecular basis of the Caskin1 and Mint1 interaction with CASK. J Mol Biol. 2011;412:3–13.
Ernst A, Sazinsky SL, Hui S, Currell B, Dharsee M, Seshagiri S, et al. Rapid evolution of functional complexity in a domain family. Sci Signal. 2009;2:ra50.
Hsueh Y-P. The role of the MAGUK protein CASK in neural development and synaptic function. CMC. 2006;13:1915–27.
Hsueh Y-P. A versatile player. J Mol Biol. 2011;412:1–2.
Stafford RL, Hinde E, Knight MJ, Pennella MA, Ear J, Digman MA, et al. Tandem SAM domain structure of human Caskin1: a presynaptic, self-assembling scaffold for CASK. Structure. 2011;19:1826–36.
Pesti S, Balázs A, Udupa R, Szabó B, Fekete A, Bőgel G, et al. Complex formation of EphB1/Nck/Caskin1 leads to tyrosine phosphorylation and structural changes of the Caskin1 SH3 domain. Cell Commun Signal. 2012;10:36.
Balázs A, Csizmok V, Buday L, Rakács M, Kiss R, Bokor M, et al. High levels of structural disorder in scaffold proteins as exemplified by a novel neuronal protein, CASK-interactive protein1. FEBS J. 2009;276:3744–56.
Kaneko T, Kumasaka T, Ganbe T, Sato T, Miyazawa K, Kitamura N, et al. Structural insight into modest binding of a non-PXXP ligand to the signal transducing adaptor molecule-2 Src homology 3 domain. J Biol Chem. 2003;278:48162–8.
Musacchio A, Saraste M, Wilmanns M. High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides. Nat Struct Biol. 1994;1:546–51.
Kobashigawa Y, Sakai M, Naito M, Yokochi M, Kumeta H, Makino Y, et al. Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK. Nat Struct Mol Biol. 2007;14:503–10.
Kaneko T, Huang H, Zhao B, Li L, Liu H, Voss CK, et al. Loops govern SH2 domain specificity by controlling access to binding pockets. Sci Signal. 2010;3:ra34–4.
Liu Q, Berry D, Nash P, Pawson T, McGlade CJ, Li SS-C. Structural basis for specific binding of the Gads SH3 domain to an RxxK motif-containing SLP-76 peptide: a novel mode of peptide recognition. Mol Cell. 2003;11:471–81.
Vaynberg J, Qin J. Weak protein-protein interactions as probed by NMR spectroscopy. Trends Biotech. 2006;24:22–7.
Vaynberg J, Fukuda T, Chen K, Vinogradova O, Velyvis A, Tu Y, et al. Structure of an ultraweak protein-protein complex and its crucial role in regulation of cell morphology and motility. Mol Cell. 2005;17:513–23.
Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 1995;6:277–93.
Johnson BA. Using NMRView to visualize and analyze the NMR spectra of macromolecules. Methods Mol Biol. 2004;278:313–52.
Shen Y, Delaglio F, Cornilescu G, Bax A. TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J Biomol NMR. 2009;44:213–23.
Güntert P, Buchner L. Combined automated NOE assignment and structure calculation with CYANA. J Biomol NMR. 2015;62:453-471.
Linge JP, Williams MA, Spronk CAEM, Bonvin AMJJ, Nilges M. Refinement of protein structures in explicit solvent. Proteins. 2003;50:496–506.
Schwieters CD, Kuszewski JJ, Tjandra N, Clore GM. The Xplor-NIH NMR molecular structure determination package. J Magn Reson. 2003;160:65–73.